Dabrafenib (GSK2118436)

Dabrafenib (GSK2118436) Suppliers list
Company Name:Beijing Allien Pharmceutical Technology Co. Ltd.  Gold
Tel:0316-7793170, 18911620176
Email:allienpharm@gmail.com
Products Intro: Product Name:Dabrafenib (GSK2118436)
CAS:1195765-45-7
Purity:HPLC>95% Package:5g;25g;50g;500g;1000g
Company Name:EASON Chemical Co., LIMITED  Gold
Tel:15157289797 13566878689
Email:info@seasonsbio.com
Products Intro: Product Name:DABRAFENIB
CAS:1195765-45-7
Purity:98% HPLC Package:1g;10g;100g;1kg Remarks:Research use
Company Name:Chongqing Chemieliva Pharmaceutical Co., Ltd.  Gold
Tel:+86 (23) 6777-0219
Email:jessica.hu@chemieliva.com
Products Intro: Product Name:Dabrafenib
CAS:1195765-45-7
Purity:98% Package:1G/2G/5G
Company Name:Nuozhan Chemistry Technology (shanghai)Co.,Ltd.  Gold
Tel:13391359909 QQ:3032858343
Email:sales@rz-chem.com
Products Intro: Product Name:Dabrafenib
CAS:1195765-45-7
Purity:98% Package:1g, 10g
Company Name:Jinan Trio PharmaTech Co., Ltd.  Gold
Tel:+86 (531) 88811793;+86 (531) 88811783;+(0)18854807083;
Email:sales@trio-pharmatech.com (International market);trio@trio-pharmatech.com(Domestic market)
Products Intro: Product Name:Dabrafenib (GSK2118436)
CAS:1195765-45-7
Purity:99% Package:5g, 10g, 20g, 50g
Dabrafenib (GSK2118436) Basic information
Product Name:Dabrafenib (GSK2118436)
Synonyms:Dabrafenib;N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;Dabrafenib free base(GSK2118436A);Dabrafenib (GSK2118436);GSK2118436A;Dabrafenib (GSK2118436A);Dabrafenib KB-57246;Debrafenib API
CAS:1195765-45-7
MF:C23H20F3N5O2S2
MW:519.5624096
EINECS:
Product Categories:Raf B protein kinase inhibitor;inhibitor;MAPK
Mol File:1195765-45-7.mol
Dabrafenib (GSK2118436) Structure
Dabrafenib (GSK2118436) Chemical Properties
density 1.443
Safety Information
MSDS Information
Dabrafenib (GSK2118436) Usage And Synthesis
Dabrafenib (GSK2118436) Preparation Products And Raw materials
Tag:Dabrafenib (GSK2118436)(1195765-45-7) Related Product Information
Y27632 (hydrochloride) MK-2206 2HCl Trametinib (GSK1120212) Ibrutinib 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaMide